Altre lingue CURE BIOT OTC Markets

Azioni

CUBT

US23128N2071

Mercato chiuso - OTC Markets Altri mercati azionari 21:59:39 11/06/2024			Variaz. 5gg	Var. 1 gen.
0,0155 ^USD	-10,78%		-18,29%	-27,11%

06/05	Curative Biotechnology, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Curative Biotechnology, Inc. ha ritirato la sua IPO per un importo di 7,999998 milioni di dollari.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/05
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	22/03
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors	08/01
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	25/11
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors	31/10/23
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	07/09/23
Curative Biotechnology, Inc. Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	07/06/23
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions	06/06/23
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation	24/05/23
Curative Biotechnology, Inc. Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/01/23
Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study	05/01/23
Curative Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	16/11/22
Curative Biotechnology, Inc. has filed an IPO in the amount of $7.999998 million.	07/11/22
Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $8 million.	31/10/22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/09/22
Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange	27/09/22
Curative Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/09/22
Curative Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/06/22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/06/22
Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/06/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CURE BIOT OTC Markets

Azioni

CUBT

US23128N2071

Altre lingue

Filtri